Hyperion Adds Venture Debt

Hyperion Therapeutics Inc., a San Francisco-based drug company focused on gastroenterology and hepatology, has secured $15 million in debt financing from Comerica Bank. The company also announced several new executives. Hyperion recently announced that it had raised $40 million in second-round funding from Sofinnova Ventures, Highland Capital Partners, New Enterprise Associates and WRF Capital. www.hyperiontx.com